Today: 10 June 2026
AI stocks slide today as Nvidia drops after Intel confirms $5 billion stake sale

AI stocks slide today as Nvidia drops after Intel confirms $5 billion stake sale

NEW YORK, December 29, 2025, 14:06 ET — Regular session

  • Nvidia led a pullback in AI-linked stocks after Intel disclosed it completed a $5 billion share sale to the chip designer.
  • Broadcom, Palantir and other AI bellwethers also fell as year-end, holiday-thinned trading kept moves choppy.
  • Investors are watching Federal Reserve minutes and weekly jobless claims later this week for fresh clues on the rate outlook.

Artificial intelligence (AI) stocks slipped on Monday afternoon, with Nvidia down about 1.7% after Intel said it had completed a $5 billion private share sale to the chip designer.

The move matters now because a small group of AI-heavyweights has driven much of the market’s momentum, leaving investors quick to adjust risk when the leaders wobble.

Trading has also turned thin in the holiday week, a setup that can exaggerate swings when big funds rebalance portfolios into year-end, Reuters reported.

In a Form 8-K, Intel said it issued and sold 214,776,632 shares to Nvidia at $23.28 per share, completing the transaction on Dec. 26 in a private placement — a direct sale to a single buyer rather than the open market.

Nvidia was last down about 1.7% at $187.33, while Intel was up roughly 0.25% at $36.29.

Other AI bellwethers were lower as well, with Broadcom down about 0.7%, Palantir off roughly 1.8% and AMD down about 0.2%.

“This is not the beginning of the end of the tech dominance, it’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford Trust. Reuters

Cloud and ad-platform stocks tied to AI spending also eased, with Microsoft down about 0.4%, Alphabet off roughly 0.3% and Meta down close to 1%.

The pullback comes as traders look for signs of a “Santa Claus rally” — the seasonal tendency for stocks to rise in the last five trading days of the year and the first two of January — even as tech leadership cools, Reuters reported. Reuters

What comes next is mostly macro: investors are watching minutes from the Fed’s prior meeting and weekly jobless claims in an otherwise light data week, Reuters said.

For AI stocks, the near-term question is whether buyers return once year-end selling and position-squaring passes, or whether profit-taking spreads after a strong run in the sector.

Intel said the share sale followed a securities purchase agreement signed in September, and it pointed to its earlier disclosure of the deal at that time.

Stock Market Today

  • Outlook Therapeutics Shares Jump 26% on FDA Fast-Track Review for Lytenava
    June 10, 2026, 5:57 PM EDT. Outlook Therapeutics shares surged about 26% to $0.89 on heavy volume as the FDA designated its Lytenava (ONS-5010) resubmission a Class 1 review, triggering a faster 60-day decision timeline. The drug targets wet age-related macular degeneration (wet AMD), a vision-impairing condition. The FDA's ruling follows an appeal overturning earlier efficacy concerns and reclassifies the application for expedited review. Despite the stock's gains, Outlook remains below the $1 Nasdaq compliance threshold, raising concerns over dilution. CEO Bob Jahr called the update a testament to the company's strong application. Lytenava, an anti-VEGF therapy, would compete with Roche and Regeneron products in the lucrative U.S. wet AMD market.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Previous Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

MongoDB stock slides as “MongoBleed” exploitation warning puts database security in focus
Next Story

MongoDB stock slides as “MongoBleed” exploitation warning puts database security in focus

Go toTop